臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yang c y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 111-135 of 1283 (52 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-03-07T07:05:49Z	Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis	Lin H.-H.; JEN-KUANG LEE; Yang C.-Y.; Lien Y.-C.; Huang J.-W.; Wu C.-K.
臺大學術典藏	2022-03-07T07:05:48Z	Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis	Huang J.-W.; Lien Y.-C.; Yang C.-Y.; Liu K.-L.; Wu C.-F.; Yen C.-J.; Wu C.-K.; JEN-KUANG LEE; Ho S.-R.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Shyu R.-S.; Hung K.-Y.
臺大學術典藏	2022-03-07T07:05:43Z	Measurement of visceral Fat: Should we include	Hung C.-S.; JEN-KUANG LEE; Yang C.-Y.; Hsieh H.-R.; Ma W.-Y.; Lin M.-S.; Liu P.-H.; Shih S.-R.; Liou J.-M.; Chuang L.-M.; Chen M.-F.; Lin J.-W.; Wei J.-N.; Li H.-Y.
臺大學術典藏	2022-03-04T05:33:38Z	Programmed cell death-ligand 1 expression in surgically resected stage i pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes	Yang C.-Y.; Lin M.-W.; Chang Y.-L.; CHEN-TU WU; Yang P.-C.
臺大學術典藏	2022-03-04T05:33:34Z	PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy	Chang Y.-L.; Yang C.-Y.; Lin M.-W.; CHEN-TU WU; Yang P.-C.
臺大學術典藏	2022-03-04T05:33:33Z	Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage i pulmonary squamous cell carcinoma	Yang C.-Y.; Lin M.-W.; Chang Y.-L.; CHEN-TU WU; Yang P.-C.
臺大學術典藏	2022-03-04T05:33:33Z	High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma	Chang Y.-L.; Yang C.-Y.; Lin M.-W.; CHEN-TU WU; Yang P.-C.
臺大學術典藏	2022-03-04T05:33:32Z	High PD-L1 expression is associated with stage IV disease and poorer overall survival in 186 cases of small cell lung cancers	Chang Y.-L.; Yang C.-Y.; Huang Y.-L.; CHEN-TU WU; Yang P.-C.
臺大學術典藏	2022-03-04T05:33:32Z	The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas	Lin M.-W.; Yang C.-Y.; Kuo S.-W.; CHEN-TU WU; Chang Y.-L.; Yang P.-C.
臺大學術典藏	2022-03-04T05:33:32Z	Globo H expression is associated with driver mutations and PD-L1 expressions in stage i non-small cell lung cancer	Yang C.-Y.; Lin M.-W.; Chang Y.-L.; CHEN-TU WU
臺大學術典藏	2022-03-04T05:33:29Z	The Differences in Clinicopathologic and Prognostic Characteristics Between Surgically Resected Peripheral and Central Lung Squamous Cell Carcinoma	Lin M.-W.; Huang Y.-L.; Yang C.-Y.; Kuo S.-W.; CHEN-TU WU; Chang Y.-L.
臺大學術典藏	2022-03-04T05:33:28Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-03-04T05:33:27Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-03-04T03:48:16Z	Repeated cycles of high-dose intravenous immunoglobulin and plasmapheresis for treatment of late antibody-mediated rejection of renal transplants	Lee C.-Y.; WEI-CHOU LIN; Wu M.-S.; Yang C.-Y.; Yeh C.-C.; Tsai M.-K.
臺大學術典藏	2022-03-04T03:48:06Z	Prognostic factors for renal transplant graft survival in a retrospective cohort of 1000 cases: The role of desensitization therapy	Lee C.-Y.; Yang C.-Y.; WEI-CHOU LIN; Chen C.-C.; Tsai M.-K.
臺大學術典藏	2022-03-04T03:48:05Z	Two-year protocol biopsy after kidney transplantation in clinically stable recipients – a retrospective study	Chen C.-C.; WEI-CHOU LIN; Lee C.-Y.; Yang C.-Y.; Tsai M.-K.
臺大學術典藏	2022-02-21T03:52:35Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2022-02-21T03:52:33Z	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations	Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; JIH-HSIANG LEE; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-21T03:52:32Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-21T03:52:31Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-21T03:52:30Z	Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC	Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H.
臺大學術典藏	2022-02-18T08:47:02Z	Gastrointestinal: Dissecting esophageal hematoma with a Mallory-Weiss tear	CHIEN-CHUAN CHEN; Yang C.-Y.; Wang H.-P.; Lin J.-T.; Wu M.-S.
臺大學術典藏	2022-02-14T07:10:41Z	Successful management of a ROS1-rearranged pulmonary pleomorphic carcinoma using serial tyrosine kinase inhibitors	Wu C.-W.; Yang C.-Y.; YIH-LEONG CHANG; Shih J.-Y.
臺大學術典藏	2022-02-14T07:10:40Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-14T07:10:39Z	Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis	Liang C.-W.; Yang C.-Y.; Flavin R.; Fletcher J.A.; Lu T.-P.; Lai I.-R.; Li Y.-I.; YIH-LEONG CHANG; Lee J.-C.

Showing items 111-135 of 1283 (52 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2856565
	???header.visitor??? : 53425619 ???header.onlineuser??? : 654 ???header.sponsordeclaration???